Strategic Growth Quantum Surgical has recently expanded via acquisitions, notably acquiring NeuWave Medical to form Precision IO Group, signaling aggressive market expansion and integration opportunities for complementary tumor ablation technologies and regional sales alignment.

Global Footprint With headquarters in Miami and additional offices in Montpellier, France, plus recent expansion in Taiwan through a partner, there are multi-region selling opportunities and cross-border service/support needs for the Epione platform and related robotics solutions.

Clinical Collaborations Active partnerships and scientific collaborations with prestigious institutions (Paoli-Calmettes Institute) and medical centers (Rush University) create entry points for co-development, clinical trials, and funded studies that can drive adoption and case-based selling.

Financial Momentum Significant funding and recent financing (€30M loan from EIB with InvestEU, $32.4M loan) indicate available capital for hardware deployments, service contracts, and expanded installation pipelines, suggesting readiness for larger customer projects.

Reference Pipeline Having treated over 1,400 patients worldwide and recognition via innovation awards positions the Epione platform as a credible, high-tech option; leverage these references and accolades to accelerate ROI-focused discussions with hospitals and interventional radiology departments.